Follow The Filings

H Hyatt Hotels Corporation

Consumer Discretionary, filed as HYATT HOTELS CORP (COM CL A), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 2

  • 2 Owners
  • Max 2.1%
  • $1.4B
  • 1 add 2 exits

In 2026 Q2 Ron Baron added to Hyatt Hotels, while Senator Investment Group and Farallon Capital Management sold out.

Who owns this now

Largest portfolio weights among holders, up to 2.1% (Ron Baron, Bamco Inc. (Baron Capital)). Not free-float ownership.

  1. Ron Baron Add 2.1%
  2. Mason Hawkins 0.08%

Who owns H

Sorted by value, long equity only, as of 2026 Q2.

History
Ron Baron, Bamco Inc. (Baron Capital) 2.1% Add +14.8% 7,279,087 $1.4B History
Mason Hawkins, Southeastern Asset Management 0.08% Hold 7,733 $1.5M History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 0.03% Exit −0.03% 36,000 $5.2M History
Senator Investment Group exited 2026 Q2 Last 2026 Q1 0.07% Exit −0.07% 9,939 $1.4M History

2 current, 2 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by H's executives, directors and 10% owners in the last 12 months, from their Form 4s

All H insider trades
  • None no insider bought on the open market
  • $137M sold by 12 insiders outside a trading plan
  • $2.6M sold by 2 insiders under 10b5-1 plans
  1. Margaret C. Egan See Remarks
    Sale
    $205K 1,100 shares at $186.78 3.2% of stake
    Traded Nov 3 Filed Nov 5
    ↗
  2. Mark R Vondrasek See Remarks
    Sale
    $963K 5,072 shares at $189.77 36% of stake
    Traded Nov 4 Filed Nov 5
    ↗
  3. Mark Samuel Hoplamazian See Remarks
    Sale
    $16M 85,000 shares at $188.23 24% of stake
    Traded Nov 3–4 Filed Nov 5
    ↗
  4. Joan Bottarini See Remarks
    Planned sale
    $314K 1,826 shares at $172.00 8.3% of stake
    Traded Oct 16 Filed Oct 19
    ↗
  5. Amar Lalvani See Remarks
    Sale
    $222K 1,364 shares at $163.06 100% of stake
    Traded Sep 14 Filed Sep 16
    ↗
  6. Susan D Kronick Director
    Planned sale
    $306K 1,700 shares at $179.88 5.4% of stake
    Traded Aug 17 Filed Aug 18
    ↗
  7. Joan Bottarini See Remarks
    Planned sale
    $311K 1,825 shares at $170.37 7.7% of stake
    Traded Aug 3 Filed Aug 4
    ↗
  8. Mark Samuel Hoplamazian See Remarks
    Sale
    $23.9M 120,000 shares at $198.93 25% of stake
    Traded Jun 18–22 Filed Jun 23
    ↗
  9. David Udell See Remarks
    Sale
    $392K 2,087 shares at $188.00 11% of stake
    Traded Jun 2 Filed Jun 3
    ↗
  10. Mark R Vondrasek See Remarks
    Sale
    $1.5M 8,200 shares at $185.26 48% of stake
    Traded May 29 Filed Jun 1
    ↗
  11. Peter Sears See Remarks
    Sale
    $1.9M 10,217 shares at $185.66 62% of stake
    Traded May 29 Filed Jun 1
    ↗
  12. Cary D McMillan Director
    Sale
    $196K 1,119 shares at $174.96 100% of stake
    Traded May 22 Filed May 26
    ↗
  13. Susan D Kronick Director
    Planned sale
    $195K 1,119 shares at $174.51 3.5% of stake
    Traded May 22 Filed May 26
    ↗
  14. David Udell See Remarks
    Sale
    $1.5M 8,682 shares at $172.00 39% of stake
    Traded May 18 Filed May 20
    ↗
  15. Susan D Kronick Director
    Planned sale
    $289K 1,700 shares at $169.96 5.2% of stake
    Traded May 15 Filed May 18
    ↗

Also filed in the last 12 months, not counted as buying or selling: 50 option exercises, 43 share withholdings for taxes, 30 stock grants, 13 sales back to the company, 3 conversions, and 2 gifts.

Congress

1 member of Congress traded H in the last three years: 1 buy and 1 sale. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Oct 14, 2025 filed Nov 21, 2025
  2. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Jun 17, 2025 filed Aug 13, 2025

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
424B2 Filing Doc
424B5 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated about 20 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $6.67B $6.65B $7.1B
Net income $0.22B $1.3B -$0.052B
Net margin * 3.3% 19.5% -0.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $2.13B $2.73B $2.18B
Total non-current assets * $10.7B $10.59B $11.86B
Total assets $12.83B $13.32B $14.04B
Total current liabilities $3.58B $3.27B $2.89B
Total non-current liabilities * $5.69B $6.22B $7.48B
Total equity $3.56B $3.55B $3.33B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $800M $633M $379M
Cash from investing -$365M $81M $357M
Cash from financing -$578M -$618M -$954M
Net change in cash -$148M $96M -$227M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf